IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,449 | -7.5% | 757,951 | +43.1% | 0.00% | 0.0% |
| Q2 2023 | $3,730 | +46.3% | 529,592 | +27.0% | 0.00% | +100.0% |
| Q1 2023 | $2,550 | -36.8% | 417,160 | -33.9% | 0.00% | -50.0% |
| Q4 2022 | $4,033 | -99.9% | 630,950 | +61.5% | 0.00% | -50.0% |
| Q3 2022 | $3,742,000 | +681.2% | 390,606 | +799.7% | 0.00% | – |
| Q2 2022 | $479,000 | -60.8% | 43,415 | -40.7% | 0.00% | -100.0% |
| Q1 2022 | $1,221,000 | +435.5% | 73,264 | +515.5% | 0.00% | – |
| Q4 2021 | $228,000 | -70.0% | 11,904 | -61.5% | 0.00% | – |
| Q3 2021 | $761,000 | -67.6% | 30,890 | -65.8% | 0.00% | -100.0% |
| Q2 2021 | $2,350,000 | +8.5% | 90,263 | +32.0% | 0.00% | 0.0% |
| Q1 2021 | $2,166,000 | -29.9% | 68,394 | +2.7% | 0.00% | -50.0% |
| Q4 2020 | $3,090,000 | +59.2% | 66,573 | +12.9% | 0.00% | +100.0% |
| Q3 2020 | $1,941,000 | -63.2% | 58,956 | -69.4% | 0.00% | -75.0% |
| Q2 2020 | $5,281,000 | +44.8% | 192,379 | +57.9% | 0.00% | +33.3% |
| Q1 2020 | $3,648,000 | -38.3% | 121,816 | -43.0% | 0.00% | 0.0% |
| Q4 2019 | $5,915,000 | +207.9% | 213,681 | +102.5% | 0.00% | +200.0% |
| Q3 2019 | $1,921,000 | +4.5% | 105,512 | +40.8% | 0.00% | 0.0% |
| Q2 2019 | $1,838,000 | +244.2% | 74,934 | +33.7% | 0.00% | – |
| Q1 2019 | $534,000 | -0.9% | 56,028 | +17.1% | 0.00% | – |
| Q3 2018 | $539,000 | +222.8% | 47,860 | +267.8% | 0.00% | – |
| Q2 2018 | $167,000 | -42.6% | 13,014 | -24.6% | 0.00% | – |
| Q1 2018 | $291,000 | +1.7% | 17,261 | -51.8% | 0.00% | – |
| Q4 2017 | $286,000 | +1044.0% | 35,799 | +1006.3% | 0.00% | – |
| Q3 2017 | $25,000 | – | 3,236 | +7990.0% | 0.00% | – |
| Q2 2017 | $0 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |